Home-based walking program for veterans with peripheral artery disease
Official title: Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease (TREK-PAD)
Run by VA Office of Research and Development · NCT06033924 · Data updated 2026-11-12
This study is testing two ways to deliver a home walking program for veterans with peripheral artery disease to see if it helps them walk farther and feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 3 sites (Birmingham, Alabama and 2 other locations) |
| Status | Recruiting |
| Started | July 1, 2024 |
| Main results expected | October 29, 2027 |
| Study ends | October 29, 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06033924 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are veterans diagnosed with lower extremity PAD who are able to walk at least one city block and have a sedentary lifestyle.
✕Probably not a fit
Patients with severe comorbidities that limit walking or those who are wheelchair-bound will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates two methods of delivering a home-based walking program for veterans with peripheral artery disease (PAD). Participants will be randomized to receive either a web-based or telehealth-delivered walking program, or usual care. The program includes step count goals, healthy walking information, and motivational messages, and lasts for a total of 36 weeks. The study aims to assess improvements in walking distance and quality of life among participants. Additionally, those who do not respond to their initial program may be re-randomized to a combination of both delivery methods.
Why it matters
Potential benefit: If successful, this program could significantly improve walking ability and quality of life for veterans with peripheral artery disease.
How similar studies have gone: Other studies have shown success with similar home-based walking interventions, indicating potential for positive outcomes in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women * Diagnosis of lower extremity PAD due to atherosclerosis * Claudication with walking defined as stage 1-3 on the Rutherford Scale * Medical clearance from the patient's primary care provider or vascular care provider * Ability to walk at least one city block * Self-reported sedentary behaviors defined as \< 150 minutes per week of physical activity * Access to a phone and/or email \& Internet * Competent to provide informed consent Exclusion Criteria: * Life expectancy of less than six months * Comorbidities that limit walking to a severe degree (i.e., wheelchair-bound) * Resident of a nursing home * Recent enrollment in an exercise program or performing 150 minutes per week or more of exercise * Planned revascularization or amputation in the next two months * Recent CVD events (\< 3 months) including stroke/TIA, MI, UA, PCI/CABG * Unstable cardiac conditions (severe valve disease, NYHA class III-IV heart failure, untreated complex congenital heart disease, or complex arrhythmias) * Current substance abuse * Psychiatric disorder which limits the patient's ability to follow the study protocol * Pregnancy * Inability to speak and read English
Where it's running
-
VA Palo Alto Health Care System, Palo Alto, CA
Palo Alto, California, United States Recruiting -
Birmingham VA Medical Center, Birmingham, AL
Birmingham, Alabama, United States Not yet recruiting -
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, United States Not yet recruiting
Study contacts
- Principal investigator: Elizabeth A Jackson, MD — Birmingham VA Medical Center, Birmingham, AL
- Study coordinator: Elizabeth A Jackson, MD
- Email: elizabeth.jackson2@va.gov
- Phone: (205) 933-8101
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Antiplatelet-Only versus Antiplatelet plus Low-Dose Rivaroxaban after Heart Events
In adults 65 or older with prior heart events and certain arterial diseases, this study tests whether continuing clopidogrel alone is no worse than adding low-dose rivaroxaban to aspirin-based therapy.
-
Home-based Pedal Exerise Therapy for Moderate-to-Severe PAD
This pilot study tests whether a 12-week home-based pedal exerciser program, guided remotely, can help adults with moderate-to-severe PAD improve walking and function.
-
Super-resolution ultrasound imaging for peripheral artery disease
This project will test whether super-resolution contrast ultrasound can reveal small-vessel problems in adults with or without peripheral artery disease.
-
Obstructive sleep apnea prevalence in people with peripheral artery disease
This project will test how common obstructive sleep apnea is in adults with peripheral artery disease by using sleep polygraphy during routine care.
-
Using wearable activity trackers and a mobile app to help people with peripheral artery disease walk better
This project will test whether a personalized home walking program guided by wearable activity trackers and automatic feedback can help people with peripheral artery disease walk as well as supervised exercise sessions.
-
Evaluating a Paclitaxel Coated Balloon for Treating Atherosclerosis in Leg Arteries
This study is testing a special balloon treatment to see if it can safely improve blood flow and reduce symptoms in people with blocked leg arteries due to peripheral artery disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.